Recently added

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

CASSIER, Philippe; Gomez-Roca, Carlos; Korakis, Iphigenie; Champiat, Stephane; GARRALDA, Elena; Galvao, Vladimir (Elsevier, 2025-02-18)

Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival

Canale, Matteo; Angeli, Davide; Tedaldi, Gianluca; Priano, Ilaria; Urbini, Milena; Petracci, Elisabetta (Dove Medical Press, 2025-02-20)

A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer

Balaguer-Montero, Maria; Marcos Morales, Adrià; Leiva, David; Atlagich, Luz M.; Staikoglou, Nikolaos; Monreal, Camilo; Hernando, Jorge; Garcia-Alvarez, Alejandro; Elez, Elena; Ligero, Marta; Zatse, Christina; Viaplana, Cristina; Mateo, Joaquin; Salvà, Francesc; Capdevila Castillon, Jaume; Dienstmann, Rodrigo; GARRALDA, Elena; Perez-Lopez, Raquel (Elsevier, 2025-04-15)

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors

El-Khoueiry, Anthony; Thomas, Jacob; Livings, Claire; Hintzen, Gabriele; Saavedra, Omar; GARRALDA, Elena (American Association for Cancer Research, 2025-04-01)

Genetic immune escape in cancer: timing and implications for treatment

Chowell, Diego; Martínez-Jiménez, Francisco (Elsevier, 2025-04)

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival

A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors

Genetic immune escape in cancer: timing and implications for treatment

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers ﻿

Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival ﻿

A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer ﻿

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors ﻿

Genetic immune escape in cancer: timing and implications for treatment ﻿

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival

A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors

Genetic immune escape in cancer: timing and implications for treatment